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Dear Editor,
In this paper, Davies et al. 1 suggest that the prevalence of abnormal smears in the HIV cohort in women with a CD4 cell count > 350 cells/mm 3 (6.3%) is similar to the prevalence of abnormal smears in the general population (6.6%-7.2%). However, we feel that this conclusion is erroneous. The data for HIV-positive women were collected for 12 months. However, the national cervical screening programme recommends that women have smears every three years under the age of 50 and every five years to age 65. 2 Therefore, the correct comparison would have been the prevalence of abnormal smears in the HIV cohort in any three-year period, assuming many were aged under 50. Whilst the accumulation of annual smears over a three-year period may give a higher three-year prevalence than single smears over the same three-year period (due to falsenegative results in the three-yearly smears), it is still likely that the prevalence of abnormalities in the HIV-cohort would have been much higher.
An audit of the data for our cohort shows that the three-yearly prevalence (2013-2015) of abnormal smears is 18%. In our audit, there were 346 HIV infected women of which 65/346 (18.8%) had one or more abnormal smears. Only six of those (9%) with abnormal smears, had CD4 cell counts < 350 cells/ mm 3 and six (9%) were not on antiretroviral therapy (ART). Only one woman with an abnormal smear had both a CD4 cell count < 350 cells/mm 3 and was not on ART. There was no significant difference between smear result based upon age, CD4 cell count, ART use or viral load. In other words, the rate of abnormal smears seems to be three times higher than the national prevalence. Whilst these data do not prove that annual smears are more beneficial than three-yearly smears in HIV-positive women, they do not support a change from the current practice. We plan to publish more complete data at a later date.
As the authors suggest, more research is required to try and ascertain if a change from yearly to two-or three-yearly smears would increase the risk of HIVpositive women developing cervical cancer.
